- Home
- KXIN vs BDRX Comparison
KXIN vs BDRX Comparison
Compare KXIN & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- BDRX
- Stock Information
- Founded
- KXIN 2015
- BDRX 2000
- Country
- KXIN China
- BDRX United Kingdom
- Employees
- KXIN N/A
- BDRX N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- BDRX Health Care
- Exchange
- KXIN Nasdaq
- BDRX Nasdaq
- Market Cap
- KXIN 13.0M
- BDRX 5.8M
- IPO Year
- KXIN N/A
- BDRX N/A
- Fundamental
- Price
- KXIN $0.97
- BDRX $0.86
- Analyst Decision
- KXIN
- BDRX
- Analyst Count
- KXIN 0
- BDRX 0
- Target Price
- KXIN N/A
- BDRX N/A
- AVG Volume (30 Days)
- KXIN 83.4K
- BDRX 3.1M
- Earning Date
- KXIN 01-01-0001
- BDRX 04-11-2025
- Dividend Yield
- KXIN N/A
- BDRX N/A
- EPS Growth
- KXIN N/A
- BDRX N/A
- EPS
- KXIN N/A
- BDRX N/A
- Revenue
- KXIN N/A
- BDRX N/A
- Revenue This Year
- KXIN N/A
- BDRX N/A
- Revenue Next Year
- KXIN N/A
- BDRX N/A
- P/E Ratio
- KXIN N/A
- BDRX N/A
- Revenue Growth
- KXIN N/A
- BDRX N/A
- 52 Week Low
- KXIN $0.64
- BDRX $0.78
- 52 Week High
- KXIN $29.54
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- KXIN 51.96
- BDRX 36.41
- Support Level
- KXIN $0.88
- BDRX $0.83
- Resistance Level
- KXIN $1.10
- BDRX $0.90
- Average True Range (ATR)
- KXIN 0.07
- BDRX 0.11
- MACD
- KXIN 0.01
- BDRX 0.00
- Stochastic Oscillator
- KXIN 44.53
- BDRX 14.57
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.